Why Revogene C. difficile?

Revogene provides healthcare systems an opportunity to minimize the overall burden of C. difficile through improved care and efficiency by helping to reduce the risk of missing a true positive with the accuracy of molecular. Fast, actionable results enable physicians to make informed decisions about patient management and treatment resulting in reduced healthcare costs associated with isolation and antibiotics. Revogene is a flexible, reliable molecular platform that allows health systems to provide testing closer to the patient and advance the quality of care through simplified sample processing and efficient workflow.

• Efficient workflow - Sample to result in 3 easy steps

• Flexible platform - Run multiple assays with different sample types on a single run

• Platform for growth - Single analyte and multiplex testing capability

• Total solution - Can be paired with Meridian immunoassays for a scalable testing solution